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514Objective:We aimed to evaluate surgical repair of atrioventricular valve regurgitation in patients with functional
single ventricle.
Methods: The medical records of 65 consecutive patients with functional single ventricle who underwent atrio-
ventricular valve repair between January 1999 and October 2008 were reviewed retrospectively. Their character-
istics were as follows: median age, 9.5 months; median weight, 6.0 kg; atrial isomerism, 31 patients; and
hypoplastic left heart syndrome, 12 patients. Regurgitation was repaired at the palliative, Glenn, and Fontan stage
in 21, 29, and 15 patients, respectively.
Results: The overall survival was 79% and 70% at 1 and 5 years, respectively. The risk factors for mortality were
age less than 3 months (P< .001), body weight less than 4 kg (P< .001), hypoplastic left heart syndrome
(P ¼ .001), concomitant Norwood (P< .001), and the palliative stage (P ¼ .004) on the univariate analysis,
and body weight less than 4 kg (P ¼ .010, hazard ratio, 9.8; 95% confidence interval, 1.7–55.6) on the multivar-
iate analysis. Twenty patients underwent reoperation (repairs in 15; replacements in 5), and freedom from reop-
eration at 1 and 5 years was 69% and 57%, respectively. Concomitant systemic-to-pulmonary shunt (P ¼ .040)
was a risk factor for reoperation on the univariate analysis. Of the 48 survivors, 38 underwent Fontan completion,
7 underwent the Glenn procedure, and 3 are awaiting the Glenn procedure.
Conclusions: The midterm results of atrioventricular valve repair in patients with functional single ventricle were
favorable; however, young and small patients, especially those with hypoplastic left heart syndrome, still had poor
outcomes. (J Thorac Cardiovasc Surg 2010;140:514-21)With improvements in treatment strategies, surgery, and
management, the outcomes of patients with functional single
ventricle (FSV) have improved dramatically. However,
treatment of patients with FSV who have systemic atrioven-
tricular valve (AVV) regurgitation remains a clinical chal-
lenge. Knowledge is lacking about such patients, because
most related studies have focused on surgical technique,1-4
diagnosis,5,6 valve morphology,1,2 or surgical stage leading
to Fontan completion.7-11 The purpose of this study was
to evaluate a single institution’s 10-year experience with
the surgical repair of systemic AVV regurgitation in
consecutive patients with FSV and to identify the factors
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The Journal of Thoracic and Cardiovascular SurgPATIENTS AND METHODS
Study Design
We retrospectively reviewed the medical records of all consecutive pa-
tients with FSV (n ¼ 65) who had AVV regurgitation and underwent
AVV repair between January 1999 and October 2008 at Shizuoka Chil-
dren’s Hospital. This study was approved by the institutional review board
of the hospital, and the need for patient consent was waived. We focused on
systemic AVV repair and excluded tricuspid valve repair in patients with
pulmonary atresia and intact ventricular septum or Ebstein anomaly, and
closure of 1 AVV orifice with or without patch in patients with both tricus-
pid and mitral valves. Our surgical indication for AVV regurgitation was
‘‘moderate or more,’’ regardless of initial repair or re-repair, and AVV re-
pair was performed even in neonates; therefore, we had no contraindicated
cases.
The medical, operative, angiographic, and echocardiographic data for all
patients were reviewed. Information regarding their clinical status was ob-
tained from the medical records and contact with the referring cardiologist.
Echocardiographic Data
The degree of regurgitation was assessed by routine preoperative and
postoperative or predischarge transthoracic echocardiography. Each patient
had postdischarge transthoracic echocardiographic examinations conducted
at the cardiologists’ discretion and as clinically indicated. Two-dimensional
and color Doppler examinations were performed, and regurgitation was
graded as follows: 0, none; 1, trivial; 2, mild; 3, moderate; and 4, severe.
Operative Techniques and Management
To confirm the location and degree of regurgitation and to assess AVV
morphology including leaflets and subvalvular tissues, precise preoperative
transthoracic echocardiography was performed. We have routinelyery c September 2010
TABLE 1. Preoperative patient profiles
Characteristic N <3 mo
Gender (female/male) 31/34 7/9
Age at repair
Newborn 12
Infant (<3 mo/>3 mo) 4/21
>1 y 28
Primary diagnosis
Right atrial isomerism 26 8
Hypoplastic left heart syndrome 12 6
Corrected transposition of the great arteries 5
Univentricular heart 5
Left atrial isomerism 5 1
Double-outlet right ventricle 3
Unbalanced common atrioventricular canal 2
Crisscross heart 2
Others 5 1
Systemic AVV morphology
Common AVV 35 9
Tricuspid valve 20 6
Mitral valve 2
Both tricuspid and mitral valve 8 1
Dominant ventricle morphology
Right 40 12
Left 8 3
Others 17 1
Situs
Solitus 32 7
Inversus 2
Ambiguous 31 9
Apex
Right 13 2
Left 52 14
AVV, Atrioventricular valve.
Abbreviations and Acronym
AVV ¼ atrioventricular valve
CI ¼ confidence interval
FSV ¼ functional single ventricle
HLHS ¼ hypoplastic left heart syndrome
RAI ¼ right atrial isomerism
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provided that the patient is aged more than 1 month, weighs more than
3.5 kg, and does not have extracardiac total anomalous pulmonary venous
connection, pulmonary venous obstruction, or an airway or esophageal
anomaly. In young, small patients not satisfying these criteria, especially
at the palliative stage, we tried to achieve hemodynamic stability intraoper-
atively; the sternum was left open, and transthoracic echocardiography was
performed routinely in the intensive care unit.
AVV repair was performed through a median sternotomy, under cardio-
pulmonary bypass with mild-to-moderate hypothermia, and cardiac arrest
using aortic crossclamping. The repair was performed by a single surgeon,
excluding 1 emergency case of AVV re-repair. Our methods were as fol-
lows:
1. We dissected fully around the ventricle and did not suspend
the pericardium ipsilateral to the apex (to move the ventricle freely).
The pleural space ipsilateral to the apex was opened as necessary.
2. Although it is possible to approximate natural tension in the AVV
intraoperatively, it is important to note that the plane of the AVV
may be different under conditions of cardiac arrest (compared with
normal beating-heart conditions). Thus, we try to reproduce the
preoperative echocardiographic findings using careful and multiple
traction sutures, without the use of retractors where possible, regard-
less of situs or apex.
3. The AVV was tested by saline injection into the ventricles.
4. De Vega annuloplasty, involving nonspecific reduction of all leaflets
regardless of competency, was performed in the early study period.
However, we believe that regurgitant AVV in patients with FSV is
mostly caused by structural abnormalities, including abnormal clefts
and commissures, dysplastic leaflets, and elongated or shortened
chordae,1,2,10 especially in cases of atrial isomerism.12,13 Therefore,
in later cases, we favored commissural annuloplasty and closure of
abnormal clefts or commissures (leaflet apposition),6 attempting to
preserve the normal or functional leaflets and commissures.
5. An annuloplasty ring was used for only adult-sized valves, and
AVV replacement was not performed in any patient as the initial
procedure.
Decisions regarding AVV repair were influenced by the patient’s size.
When reducing the annular diameter, an acceptable opening orifice must
be maintained. Therefore, the diameter of opening orifice was measured
and determined intraoperatively. We attempted to preserve the following
opening orifice: 100% of the normal tricuspid valve annular diameter (cal-
culated from Rowlatt and colleagues’ modified equation14) at the palliative
stage, 80% of the normal tricuspid valve annular diameter at the Glenn stage
(cavopulmonary anastomosis including bidirectional Glenn, Kawashima
procedures, and hemi-Fontan), and 80% of the normal mitral valve annular
diameter at the Fontan stage.6 Additional pulmonary blood flow15 at the
Glenn stage was avoided to prevent volume overloading. Some patients
with unilateral pulmonary arterial hypoplasia require additional pulmonary
blood flow. In these patients, we used new intrapulmonary-artery septation
procedures,16 including unilateral cavopulmonary anastomosis, systemic-
to-pulmonary shunt, and septation between 2 blood sources with good
results.The Journal of Thoracic and CaStatistical Analyses
End points were overall survival, AVV reoperation, and moderate or
more recurrent AVV regurgitation. Prognostic variables examined include
continuous variables (total cardiopulmonary bypass time, aortic cross-
clamping time) and categoric variables (gender, age< 3 months, body
weight< 4 kg, primary diagnosis, AVV morphology, dominant ventricle
morphology, situs, apex, degree of preoperative AVV regurgitation, repair
procedure, single or multiple repair procedures, concomitant surgical proce-
dure, and surgical stage leading to Fontan completion). AVV reoperation
was also tested as a possible predictor of mortality.
Continuous variables are summarized as the median value and range or
the mean standard deviation as appropriate. Data from groups were com-
pared with the Fisher’s exact test, chi-square test, or Wilcoxon rank-sum
test as appropriate. Actuarial survival, freedom from AVV reoperation,
and freedom from AVV reoperation or moderate or more recurrent AVV
regurgitation were estimated by the Kaplan–Meier method, and 95% con-
fidence intervals (CIs) were constructed around the curves according to
Greenwood’s formula.
These clinical variables were analyzed using the Cox regression hazard
model for continuous variables and the log-rank test for categoric variables
on univariate analysis. Variables with P values of less than .1 on the univar-
iate analysis were entered as candidates into the Cox model for multivariate
analysis. Hazard ratios with 95% CIs were constructed for the significant
multivariate predictors. The Dr SPSS II statistical software for Windows
(SPSS, Inc, Chicago, Ill) was used for data analysis.rdiovascular Surgery c Volume 140, Number 3 515
TABLE 2. Timing of atrioventricular valve repair
Primary diagnosis
Timing of repair N <3 mo <4 kg HLHS RAI cTGA LAI Others
Palliative stage
Initial palliation
Systemic-to-pulmonary shunt 8 7 7 6 2
Norwood procedure 5 5 5 5
Pulmonary artery banding 3 1 1 2 1
Ventricle-to-pulmonary shunt 1 1 1
Interstage (before cavopulmonary anastomosis) 4 1 2 2 2
Glenn stage
Cavopulmonary anastomosis 22 1 3 2 9 2 1 8
Interstage (before Fontan) 7 1 3 2 1
Fontan stage
Fontan 11 1 2 4 2 3
After Fontan 4 1 3
Total 65 16 19 12 26 5 5 17
cTGA, Corrected transposition of the great arteries; HLHS, hypoplastic left heart syndrome; LAI, left atrial isomerism; RAI, right atrial isomerism.
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Patient Population
During the study period, 65 consecutive patients with
FSV who had AVV regurgitation underwent AVV repair.
Patient demographic and morphologic variables are shown
in Table 1. The timing of AVV repair is shown in Table 2,
and the surgical procedures performed concomitant to
AVV repair are listed in Table 3.
The median age at AVV repair was 9.5 months (range,
0 days–17 years), and the median body weight was 6.0 kg
(range, 2.5–66.0 kg). The mean follow-up period was
37.5 37.1 months, and follow-up was completed for all pa-
tients. Three patients underwentAVV repair at our institution
before the study period, and 3 patients previously underwent
AVV repair at other institutions. The mean cardiopulmonary
bypass time was 218  62 minutes. The mean aortic cross-
clamping time (n ¼ 63) was 84  27 minutes. In 2 patients,
AVV repair was performed during induced ventricular
fibrillation.TABLE 3. Surgical procedures performed concomitant to atrio-
ventricular valve repair
Concomitant surgical procedures N
Pulmonary artery angioplasty 24
Intrapulmonary artery septation 6
Extracardiac TAPVC repair 5
Release of pulmonary venous stenosis 5
DKS anastomosis 3
ECMO 3
Release of ventricular outflow tract obstruction 2
Recoarctation repair 2
Others 4
DKS,Damus–Kaye–Stansel; ECMO, extracorporeal membrane oxygenation; TAPVC,
total anomalous pulmonary venous connection.
516 The Journal of Thoracic and Cardiovascular SurgData regarding repair procedure were available for 63
patients (97%) and are shown in Table 4. Commissural an-
nuloplasty (81%) and closure of commissure or cleft (leaflet
apposition) (52%) were the predominant repair procedures.
The number of patients who underwent single procedures
was significantly higher in patients with hypoplastic left
heart syndrome (HLHS) (P ¼ .003), age less than 3 months
(P ¼ .005), and body weight less than 4 kg (P ¼ .006), and
significantly lower in the Glenn stage group (P ¼ .029)
(Table 5).
Survival
Kaplan–Meier estimated survival after AVV repair was
79% (95% CI, 68–89) and 70% (95% CI, 58–82) at 1
and 5 years, respectively (Figure 1, A). The outcomes with
regard to the timing of AVV repair and the patients’ surgical
stage are shown in Figure 2. There were 3 early deaths, 9
hospital deaths, and 5 late deaths. Of the 48 survivors, 38 un-
derwent Fontan completion, 7 underwent the Glenn proce-
dure, and 3 are awaiting the Glenn procedure.
Significant risk factors formortality on the univariate anal-
ysis were as follows: age less than 3months (P<.001), bodyTABLE 4. Atrioventricular valve repair procedures
Procedures N <3 mo
Commissural annuloplasty 51 13
Closure of commissure or cleft 33 3
Edge-to-edge repair 19 4
De Vega annuloplasty 8 3
Chordae shortening 5 0
Papillotomy 5 0
Artificial chordae 2 0
Annuloplasty ring 1 0
ery c September 2010
TABLE 5. Single or multiple procedures
Primary
diagnosis
Operation record
AVV repair
procedures
N Unavailable Available Single Multiple P
RAI 26 1 25 6 19
HLHS 12 12 8 4 .003
cTGA 5 5 5
Univentricular
heart
5 5 1 4
LAI 5 1 4 1 3
DORV 3 3 1 2
Unbalanced
CAVC
2 2 2
Criss cross
heart
2 2 2
Others 5 5 1 4
Surgical stage
Palliative
stage
21 21 9 12
Glenn stage 29 1 28 4 24 .029
Fontan stage 15 1 14 5 9
Age<3 mos 16 16 9 7 .005
Body weight
<4 kg
19 19 10 9 .006
AVV, Atrioventricular valve; CAVC, common atrioventricular canal; cTGA, corrected
transposition of the great arteries; DORV, double-outlet right ventricle; HLHS, hypo-
plastic left heart syndrome; LAI, left atrial isomerism; RAI, right atrial isomerism.
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B), concomitant Norwood procedure (P< .001), and pallia-
tive stage (P ¼ .004) (Figure 1, C). By using multivariate
Cox regression analysis, the one significant risk factor for
mortality was body weight less than 4 kg (P ¼ .010, hazard
ratio, 9.8; 95% CI, 1.7–55.6).
Atrioventricular Valve Regurgitation and
Reoperation
Postoperative echocardiographywas not performed in 2 of
the 3 patients with early death after the initial AVV repair
(these 2 patients were excluded from the analysis of freedom
from AVV reoperation, and analysis of freedom from AVV
reoperation or moderate or more recurrent AVV regurgita-
tion). Postoperative echocardiography was not performed
in 1 patient with early death after AVV re-repair. We com-
pared and evaluated both the preoperative and postoperative
regurgitation grade data of the remaining patients. In the pa-
tients who underwent AVV reoperation during the same hos-
pitalization (n ¼ 4), we evaluated the final data obtained
before reoperation. Two of these were patients with HLHS
(1 at the Glenn stage, and 1 at the Fontan stage; both treated
in the early study period), and 2were patients with right atrial
isomerism (RAI) (both at the palliative stage).
The patientswho underwentAVV repair had a preoperative
regurgitation grade of 3.4 0.5,which decreased significantly
to 2.2  1.0 on the postoperative or predischarge examina-The Journal of Thoracic and Cations (n ¼ 63; P< .001). Twenty patients underwent AVV
reoperation (repairs, 15; replacements, 5). The median inter-
val from AVV repair to reoperation was 5.9 months (range,
0.2–47.2). The patients who underwent AVV re-repair had
a preoperative regurgitation grade of 3.4  0.5, which
decreased significantly to 2.2  0.8 in the postoperative or
predischarge examinations (n ¼ 14; P< .001). Of the 46
survivors without prosthetic valves, the latest follow-up
echocardiographic regurgitation grade was 1.9  1.0.
Freedom from AVV reoperation (n¼ 63) at 1 and 5 years
was 69% (95% CI, 56–82) and 57% (95% CI, 42–72), re-
spectively (Figure 1, D). Freedom from AVV reoperation or
moderate or more recurrent AVV regurgitation (n¼ 63) at 1
and 5 years was 51% (95% CI, 38–64) and 39% (95% CI,
24–54), respectively (Figure 1, G). The cause of all reopera-
tions was regurgitation, and no reoperation was performed
because of stenosis.
A significant risk factor on the univariate analysis forAVV
reoperation was concomitant systemic-to-pulmonary shunt
(P¼ .040), whereas significant risk factors for AVV reoper-
ation or moderate or more recurrent AVV regurgitation were
age less than 3months (P¼ .021), bodyweight less than 4 kg
(P ¼ .010), concomitant systemic-to-pulmonary shunt
(P< .001), and the palliative stage (P ¼ .008) (Figure 1, I).
Onmultivariate Cox regression analysis, none reached statis-
tical significance.
There was no significant morphologic determinant on
postoperative AVV analysis. RAI was more commonly as-
sociated with AVV reoperation or moderate or more recur-
rent AVV regurgitation, but did not reach statistical
significance (P ¼ .123) (Figure 1, H).
Atrioventricular Valve Repair in Neonatal or Early
Infant Period
Sixteen patients underwent AVV repair in the neonatal
(n¼ 12) or early infant (n¼ 4) periods. Patient demographic
and morphologic variables are shown in Table 1. Four pa-
tients (25%) were diagnosed prenatally, and 12 patients
(75%) required preoperative intubation and respirator con-
trol. The data regarding repair procedure are shown in
Table 4.
Kaplan–Meier estimated survival of patients aged less
than 3 months was 59% (95% CI, 34–85) at 1 year and
34% (95% CI, 8–60) at 5 years, whereas that of patients
aged more than 3 months was 85% (95% CI, 74–95) at 1
year and 82% (95%CI, 70–93) at 5 years (P<.001). Patient
deaths included the following: 1 early death (necrotizing
cholecystitis), 6 hospital deaths (bilateral and multiple recur-
rent pulmonary venous obstruction, 2; renal failure, 1; ar-
rhythmia, 1; airway bleeding, 1; mediastinitis, 1), and 2
late deaths (1 infection and 1 sudden death). Five patients
underwent AVV reoperation (repairs, 4; replacement, 1).
Of the 7 survivors, 3 underwent AVV re-repair, and none
hadprosthetic valves. The latest follow-up echocardiographicrdiovascular Surgery c Volume 140, Number 3 517
FIGURE 1. Kaplan–Meier estimated survival: overall (A), according to diagnosis (B), and according to the surgical stage (C). Freedom from AVV reop-
eration: overall (D), according to diagnosis (E), and according to the surgical stage (F). Freedom from reoperation or moderate or more recurrent regurgitation:
overall (G), according to diagnosis (H), and according to the surgical stage (I). The number of patients at risk at 0, 1, 3, and 5 years is shown. HLHS,
Hypoplastic left heart syndrome; RAI, right atrial isomerism.
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Fontan completion, 1 patient underwent theGlenn procedure,
and 2 patients are awaiting the Glenn procedure.
Fontan Completion
Forty-one patients underwent Fontan completion with 1
hospital death (HLHS, cardiac dysfunction) and 2 late
deaths (HLHS, cardiac dysfunction; RAI, infection). Eight518 The Journal of Thoracic and Cardiovascular Surgpatients underwent Fontan completion without interim cav-
opulmonary anastomosis. The median age at Fontan com-
pletion was 29.7 months (range, 7.0–204.9 months), and
the median body weight was 10.6 kg (range, 3.8–66.0 kg).
Fenestrations were placed in 5 patients; of these patients,
a single-lung Fontan procedure (for obstruction of the
unilateral pulmonary veins) was performed in 2 patients.
Follow-up cardiac catheterizations were performed in 33ery c September 2010
FIGURE 2. Outcomes of patients with FSV after AVV repair. BDG,
Bidirectional Glenn; ED, early death; HD, hospital death; LD, late death.
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data). The interval between Fontan completion and the latest
follow-up cardiac catheterization was 38.5  33.8 months.
The hemodynamic variables were as follows: central venous
pressure, 12.9  2.6 mm Hg; cardiac index, 3.0  0.7 L/
min/m2; ejection fraction, 54.5%  12.4%; saturation,
92.9%  4.9%. At the latest follow-up, 2 patients who un-
derwent single-lung Fontan procedure were in New York
Heart Association class II and III, and the remaining 36
patients were in class I.
DISCUSSION
Treatment of patients with FSV has improved in recent
years. However, significant systemic AVV regurgitation is re-
portedly a risk factor for mortality, particularly with a diagno-
sis of HLHS, RAI, or heterotaxy syndrome.17-19 There have
been few reports on consecutive FSV patients with AVV
regurgitation and no reports on AVV repair in these patients.
Thus, the risk factors influencing their outcomes remain
poorly understood. We were able to consider all aspects
of these patients, because there were no contraindications,
exclusions, or initial valve replacement cases.
The current surgical goal for these patients is staged Fon-
tan completion. Some institutions consider heart transplanta-
tion for these patients,4,5,8-11 but this is not possible in Japan,
where pediatric heart transplantation is prohibited. Further,
although it has been shown that AVV replacement can be
performed in patients with FSV with acceptable morbidity
and mortality,4 it is preferable to avoid the use of prosthetic
valves in growing patients.
In our 10-year experience, the Kaplan–Meier estimated
survival was 79% and 70% at 1 and 5 years, respectively.
Our results seem satisfactory considering the disease sever-
ity in our patient population (newborn, 18%; RAI, 40%;
HLHS, 18%; the palliative stage, 32%).
Some reports have mentioned a size limitation of the AVV
orifice reduced by surgical repair in patients with FSV.1,2
However, blood flow through the AVV can reasonably be
expected to be different at each surgical stage; therefore, weThe Journal of Thoracic and Catried to confirm and determine the appropriate diameter of
opening orifice intraoperatively.6 Normal-sized tricuspid
valves in patientswith classic HLHS (aortic andmitral atresia)
can tolerate the total cardiac output of Norwood circulation;
therefore, 100% of the normal tricuspid valve annular diame-
ter is enough at the palliative stage. Eighty percent of the nor-
mal tricuspid valve annular diameter is equal to 95% to 99%
of the normal mitral valve annular diameter (calculated from
Rowlatt and colleagues’ modified equation14). The bidirec-
tional Glenn without additional pulmonary flow creates vol-
ume unloading; therefore, approximately 100% of the
normal mitral valve annular diameter is enough at the Glenn
stage.Wehaveused the limitation of 80%of the normalmitral
valve annular diameter formitral valve repair in patientswith 2
ventricleswithoutmajor problems.Cardiac output is limited in
Fontan circulation without fenestration and determined pri-
marily by the pulmonary vascular bed20; therefore, 80% of
the normalmitral valve annular diameter is enough at the Fon-
tan stage. In addition, collateral vessel formation after the
Glenn procedure may increase volume loading gradually.21,22
However, it may not occur after the Fontan completion
without fenestration. Therefore, we differentiated the Glenn
stage from the Fontan stage for the diameter. Because there
was no reoperation for valve stenosis, our size limitation
standard seems reasonable, reliable, and reproducible.
The choice of repair procedure for patients with FSV is an
important issue. AVV morphology varies widely, especially
with atrial isomerism,12,13 and the decision regarding the
repair procedure must be based on the preoperative and
intraoperative morphologic findings. Therefore, it is most
important to reproduce the preoperative echocardiographic
findings of the AVV with a reasonable operative field;
otherwise, the surgeon may repair an area that has no
regurgitation preoperatively, and the AVV may be
deformed. We prefer commissural annuloplasty and closure
of clefts or commissures (leaflet apposition) but cannot
prove the superiority of these repair procedures by
statistical analysis. However, because the normal or
functional leaflets and commissures can be preserved using
these techniques, we believe that they are superior to the De
Vega annuloplasty in terms of allowing future AVV re-
repair, preventing the need for AVV replacement, and reduc-
ing the size limitation at each surgical stage.
The risk factors for mortality were age less than 3 months,
bodyweight less than4kg,HLHS, concomitantNorwoodpro-
cedure, and the palliative stage on the univariate analysis, and
body weight less than 4 kg on the multivariate analysis. Pa-
tients with low body weight have small valves, limited choice
of repair procedures, and overall fragility. To summarize these
risk factors in plain language, young and small patients with
FSV, especially those with HLHS, have poor outcomes.
We have reported the first case series of AVV repairs for
neonates and early infants. Our results seem reasonable, but
not satisfactory. Overall fragility makes AVV repair difficultrdiovascular Surgery c Volume 140, Number 3 519
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repair suture for the edge of the leaflet in an autopsy case in
the early study period. Since this experience, we performed
a commissural annuloplasty procedure and avoided suturing
the edge of the leaflet to achieve sufficient strength in the re-
pair point in such small patients. It may be difficult to elimi-
nate AVV regurgitation completely in the initial repair.
Therefore, we tried to perform AVV repair several times to
achieve satisfactory control of the regurgitation (‘‘staged
AVV repair’’). We reduced the valve size limitation at each
surgical stage and increased the range of repair procedures,
including edge-to-edge repair. More than half of the causes
of death in such patientswere unrelated toAVV regurgitation
or cardiac dysfunction. Therefore, we believe that AVV re-
gurgitation can be controlled with staged intervention.
We identified concomitant systemic-to-pulmonary shunt
as the only significant risk factor for AVV reoperation on
the univariate analysis. The finding that volume overloading
in systemic-to-pulmonary shunt circulation is not compati-
ble with AVV repair is not surprising. Therefore, early bidi-
rectional Glenn is recommended. The median age of such
patients who underwent bidirectional Glenn was 6.1 months.
Early in the study period, we performed the Fontan com-
pletion with lateral tunnel during infancy (without interim
cavopulmonary anastomosis),23 even with AVV regurgita-
tion, if the patients were small and there was a need to avoid
volume overloading. However, the volume reduction of the
Glenn procedure has been shown to be effective in high-risk
Fontan candidates24 and has been widely adopted. There-
fore, because there was 1 hospital death and 1 late death after
Fontan completion (both HLHS cases with tricuspid regurgi-
tation), we adopted an interim Glenn procedure, in which
volume unloading is achieved during infancy, after which
an extracardiac conduit Fontan procedure was performed
with excellent results.25
Our surgical indication for AVV regurgitation was ‘‘mod-
erate or more.’’ However, Mahle et al10 reported that AVV
regurgitation improves in some patients after a bidirectional
Glenn procedure. Their report was based on nonrandomized
study; therefore, we could not evaluate the positive effect on
AVV regurgitation after volume unloading of a bidirectional
Glenn procedure. Moreover, it is difficult to perform a ran-
domized study, partially because of the wide variety of
AVV in patients with FSV.
To our knowledge, no previous study has shown the post-
operative hemodynamic variables after AVV repair and
Fontan completion. In our series, the hemodynamic vari-
ables were excellent considering the disease severity in our
patient population. Furthermore, our patients had main-
tained good physical status.
Study Limitations
This study has several limitations. It is a retrospective and
nonrandomized study with a relatively small number of520 The Journal of Thoracic and Cardiovascular Surgpatients. Further, the mean follow-up period was only
37.5  37.1 months. Therefore, a larger number of patients
and longer follow-up are required.
CONCLUSIONS
The midterm results of the surgical repair for AVV regur-
gitation in patients with FSV were favorable. With aggres-
sive AVV repair, cardiac function can be maintained
effectively. However, young and small patients with FSV,
especially those with HLHS, still have poor outcomes;
therefore, more efforts are required to improve their midterm
results.
The authors thank Dr Shiro Tanaka for statistical advice and re-
view of the statistical analysis in this study.
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